Keyword: Novartis

News

Actavis to Sell Generic Yaz Birth Control After Ruling

17.04.2013 - Pharmaceutical company Actavis said on Tuesday that it would once again sell a generic version of Bayer's Yaz after an appeals court ruled that Bayer's patent for the oral...

News

New Technology Speeding Progress on Bird Flu Vaccine

13.04.2013 - Even as U.S. officials this week awaited the arrival of a sample of the new bird flu virus from China - typically the first step in making a flu vaccine - government-backed...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...

News

Novartis Loses Landmark India Cancer Drug Patent Case

02.04.2013 - India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...

News

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

27.03.2013 - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...

News

Roche Stays a Step Ahead of Copycat Drugmakers

25.03.2013 - Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...

News

Health Firms Demand Bills Overhaul from Spain to Stem Debt

13.03.2013 - Healthcare companies are demanding fundamental changes to how Spain's cash-strapped regions pay their bills, worried by the reappearance of a large deficit just months after the...

News

Novartis Golden Handshake Angers Shareholders, Politicians

17.02.2013 - Pharma group Novartis' decision to pay up to 72 million Swiss francs ($77.94 million) to outgoing chairman Daniel Vasella has unleashed a wave of indignation among activist...